HIV/AIDS
GeoVax Reports Progress on Its AIDS Vaccine Technology
Published in Lab Business Week, July 27th, 2008
GeoVax Labs, Inc. (BULLETIN BOARD: GOVX) , an Atlanta based, publicly traded biopharmaceutical company specializing in the prevention and treatment of infectious diseases, today provided an operational update on the company's progress towards entering Phase 2 preventative human clinical trial testing and plans to proceed into therapeutic human trials with its AIDS vaccine. Five successful human trials evaluating GeoVax AIDS vaccines have previously been reported.
Planned Phase 2 Human Clinical Trial for Prevention of AIDS
The Company's Phase 2 trial, conducted by the U.S. National Institutes of Health (NIH) supported HIV Vaccine Trials Network...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2008-07-27)
More Articles from Lab Business Week
- Cancer Gene Therapy
Studies from Cold Spring Harbor Laboratory describe new findings in cancer gene therapy - Heart Attack
SpectraCell Laboratories Offers Additional Test for Heart Attack and Stroke Risk - Lextech Labs
Lextech Labs' iRa Brings Mobile Surveillance to the iPhone - Lextech Labs
Lextech Launches iPhone Focused Sister Company - Life Sciences
Data on life sciences published by researchers at Greenfield Laboratories - Mesa Laboratories, Inc.
Mesa Laboratories, Inc. Added to the Russell Microcap Index - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
